Biotech Investment Analyst — Drug Asset & Company Assessment
MercorLegit · not rated yetPosted on 5 Aug 2026
Pay: $120–200/hr
- Who can apply
- Open only to people in United States
- Hours
- 15 hrs/week · Part-time
- Where
- Remote, work from home
- Job type
- Response evaluation
- Openings
- 5 openings
At a glance: A part-time, remote response evaluation job with Mercor. It pays $120–200/hr for 15 hours a week. Only people in United States can apply.
Ongoing · listed since 5 Aug 2026
Mercor keeps this listing open to recruit all year. It is still open, but it isn’t a new opening.
What happens after you click Apply
- You leave AI Trainer HQ and go to Mercor’s own site.
- Upload your résumé on work.mercor.com
- Confirm your work authorization
- Sit the AI interview, which takes about 20 minutes
- Complete any written assessment attached to the listing
- On receiving an offer, sign it, configure payouts and verify your identity
How this pay compares
This job pays more than 90% of the 120 other finance & accounting jobs on the board that state pay; 10% pay more.
- This job
- $160/hrMiddle of $120–200/hr
- Median on Mercor
- $80/hrFrom 295 other paid jobs
- Median in finance & accounting
- $65/hrFrom 120 other paid jobs
Requirements
- Qualifications
- Not specified in the listing
- Languages
- English
- Equipment
- Computer with a reliable internet connection
About this job
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.
Responsibilities
• Create and critique rubrics that analyze commercial drugs and drug-development programs
• Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
• Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
• Apply your assessment across the pilot's set of companies (~5–10)
Requirements
• US-based biotech / healthcare investment analyst with a specialist-fund background
• Familiarity with biotech/pharma development programs
• Able to assess a drug asset and the company behind it end-to-end
• 5+ years evaluating biotech/pharma companies or assets
Engagement Details
• Duration: Approximately 10–20 hours over a 1–2 week pilot
• Remote — US-based
Why Participate
• Help improve expert AI evaluation of drugs and drug-development programs
• Recurring engagement for strong contributors
Listing history
- First seen on our board
- (9 days ago)
- Posted by Mercor
- Last checked
- Source
- Mercor
We check every live job against its source at least every 24 hours. How we check jobs
